SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. (SABS) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 52 transactions totaling $35.7K, demonstrating a bullish sentiment with $31.3K in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 1,800,000 shares valued at $0.
SABS Insider Activity Summary
Who Is Buying SABS Stock?
No significant insider buying has been recorded for SABS in the recent period.
Who Is Selling SABS Stock?
No significant insider selling has been recorded for SABS in the recent period.
Is SAB Biotherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SABS is bullish with an Insider Alignment Score of 94/100 and a net flow of $31.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SABS Frequently Asked Questions
Understanding SABS Insider Activity
Insider trading at SAB Biotherapeutics, Inc. (SABS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading SABS stock, having executed 52 transactions in the past 90 days. The most active insider is Capital Gp, Llc Sessa (Executive), who has made 1 transactions totaling $3.0M.
Related Tools
Track SAB Biotherapeutics, Inc. Insider Activity
Get notified when executives and directors at SABS file new Form 4 transactions